Clinical Trial Update: Study of UC-781 Vaginal Microbicide [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating UC-781 as a vaginal microbicide for HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• UC-781 vaginal microbicide (UC-781)

Snippet

Sponsor: CONRAD | Conditions: HIV Infections | Phase 1 | Status: COMPLETED